Gebäude in Al Nuaimiya,Al Nuaimiya 3,Rawan Building, 11 schlafzimmer, 50000000 AED - 17002078
Karte
11
AED50.000.000
Geschätzte Zahlung AED 179,9 Tsd./Monat
Finanzierung prüfen
Rawan Building, Al Nuaimiya 3, Al Nuaimiya, Ajman
10+ Schlafzimmer
10+ Badezimmer
929 m²

Gebäude in Al Nuaimiya,Al Nuaimiya 3,Rawan Building, 11 schlafzimmer, 50000000 AED - 17002078

Residential and Commercial Tower for Sale in Al Nuaimiya, Ajman

An excellent investment opportunity to acquire a residential and commercial tower in Al Nuaimiya, Ajman, a vibrant and strategically located area close to Dubai and Sharjah.

The property is situated in a high-demand area with strong occupancy rates, offering an attractive investment opportunity for buyers seeking rental income and long-term capital growth.

Property Details

Location: Al Nuaimiya, Ajman
Building Type: Residential and Commercial Tower
Building Height: 20 Floors
Total Units: 140 Units
Building Age: Less Than 10 Years
Return on Investment: 9%
Occupancy Rate: High

Investment Advantages

Strategic location close to Dubai and Sharjah
Situated in a busy area with access to major roads and essential services
Residential and commercial use offering diversified investment potential
High occupancy rate and strong rental demand
Established property suitable for investors seeking recurring rental income

This property presents an attractive opportunity to invest in Ajman's active real estate market, combining residential and commercial investment potential with a stated annual return of 9%.

For the asking price, annual rental income, operating expenses, and further details, please contact us to arrange a viewing.

Objektinformationen

  • TypWohngebäude
  • ZweckVerkauf
  • Referenznr.Bayut - awtan-S-07532
  • FertigstellungBezugsfertig
  • Durchschnittsmiete
  • Hinzugefügt am27. Oktober 2026

Validierte Informationen

Validated Check Mark Icon

Hypothek

Berechne und sieh dir die monatliche Hypothek für diese Wohngebäude an

Gebäudeinformationen

Validated Check Mark Icon

Trends & Indizes

Regulatorische Informationen

Für Sie empfohlen